Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sionna Therapeutics, Inc. | 19,959 | reported | 12 Jun 2025 | tx 1+19,959 |
| Upstream Bio, Inc. | 17,096 | reported | 10 Jun 2025 | tx 2+34,192 |
| CRISPR Therapeutics AG | 13,000 | reported | 05 Jun 2025 | tx 5+76,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Sionna Therapeutics, Inc. | 19,959 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Upstream Bio, Inc. | 17,096 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 10 Oct 2024 | GRANT_AWARD | Upstream Bio, Inc. | 17,096 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | CRISPR Therapeutics AG | 13,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | CRISPR Therapeutics AG | 12,000 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | CRISPR Therapeutics AG | 25,000 | 0.00 USD | deriv |